Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CATX	PERSPECTIVE THERAPEUTICS INC	$502.45M	-41.30%	-34.30%	-43.45%	-50.50%	0.29	5.17	100.00%	-11,665.30%	-11,712.44%
TVRD	TVARDI THERAPEUTICS INC	$28.33M	-98.90%	-47.40%	-86.61%	-106.70%	0.53	2.86	N/A	N/A	N/A
LONA	LEONABIO INC	$106.62M	-341.00%	-209.90%	-236.54%	-5,752.10%	2.32	1.88	N/A	N/A	N/A
SENS	SENSEONICS HOLDINGS INC	$288.22M	-102.70%	-54.90%	-62.95%	-57.30%	1.07	4.83	44.70%	-196.00%	-181.98%
CLPT	CLEARPOINT NEURO INC	$277.95M	-122.20%	-40.70%	-26.55%	-48.40%	2.49	5.91	61.40%	-69.10%	-62.47%
PRAX	PRAXIS PRECISION MEDICINES INC	$8.64B	-58.70%	-53.50%	-34.54%	-98.00%	0.07	10.22	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$458.91M	-46.30%	-42.50%	-59.73%	-65.00%	0.14	7.82	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$5.71B	-100.20%	-68.50%	-37.30%	-94.90%	0.47	14.24	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$232.86M	-64.90%	-30.20%	-30.25%	-35.60%	0.40	7.40	N/A	N/A	N/A
ALEC	ALECTOR INC	$265.97M	-225.00%	-41.00%	-63.81%	-58.80%	8.57	3.83	100.00%	-679.20%	-678.36%
BNTX	BIONTECH SE	$21.88B	-6.00%	-5.30%	-4.94%	-11.00%	0.14	7.54	77.60%	-39.60%	-34.18%
CTNM	CONTINEUM THERAPEUTICS INC	$501.80M	-30.10%	-28.30%	-22.47%	-35.30%	0.06	27.50	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.94B	-2.00%	-1.80%	-5.72%	-9.80%	0.19	5.28	100.00%	-3.70%	-11.19%
MBRX	MOLECULIN BIOTECH INC	$12.38M	N/A	-158.30%	-219.75%	808.30%	0.47	1.41	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$212.91M	-18.60%	-15.90%	-18.42%	-53.50%	0.18	6.58	41.90%	-59.80%	-58.19%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$713.09M	-85.90%	-41.90%	-32.43%	-143.60%	0.09	12.34	N/A	N/A	N/A
OWLT	OWLET INC	$143.62M	N/A	-60.80%	-87.54%	-374.10%	2.64	1.85	50.60%	-39.60%	-34.28%
ARVN	ARVINAS INC	$693.98M	-14.30%	-9.30%	-13.99%	-13.40%	0.66	4.92	100.00%	-30.80%	-30.65%
DFTX	DEFINIUM THERAPEUTICS INC	$2.06B	-84.40%	-60.40%	-47.75%	-103.80%	0.32	6.29	N/A	N/A	N/A
DCGO	DOCGO INC	$56.29M	-71.40%	-51.70%	-115.16%	-100.30%	0.63	2.26	30.70%	-56.60%	-53.47%
MSLE	SATELLOS BIOSCIENCE INC	$90.74M	-52.00%	-47.40%	-88.90%	-175.30%	0.15	7.77	N/A	N/A	N/A
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$120.95M	N/A	-111.30%	-366.30%	-844.80%	-1.82	1.27	56.70%	-1,238.50%	-1,235.83%
BCTX	BRIACELL THERAPEUTICS CORP	$29.73M	-174.50%	-140.80%	-99.17%	-849.10%	0.11	10.10	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$313.36M	-33.40%	-32.20%	-37.23%	-39.40%	0.05	15.16	N/A	N/A	N/A
NKTX	NKARTA INC	$165.39M	-30.00%	-23.80%	-27.25%	-23.60%	0.29	12.69	N/A	N/A	N/A
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$534.78M	-528.40%	-267.60%	-5,792.55%	3,181.00%	-250.00	0.73	70.30%	-4,921.30%	-4,917.46%
AGL	AGILON HEALTH INC	$178.23M	-116.60%	-24.00%	-196.84%	-215.90%	9.03	1.02	-2.70%	-6.60%	-6.46%
CNTX	CONTEXT THERAPEUTICS INC	$249.91M	-47.00%	-44.10%	-59.73%	1,838.70%	0.13	8.52	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$364.08M	-146.40%	-111.60%	-147.28%	-341.70%	0.84	5.87	N/A	N/A	N/A
HUMA	HUMACYTE INC	$142.54M	-424.80%	-32.10%	-30.19%	-27.30%	36.43	3.69	-376.10%	-2,003.60%	-1,451.57%
DYN	DYNE THERAPEUTICS INC	$3.11B	-61.50%	-50.90%	-38.72%	-132.70%	0.22	22.25	N/A	N/A	N/A
GHRS	GH RESEARCH PLC	$903.77M	-16.30%	-15.80%	-17.08%	-99.00%	0.03	34.13	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$1.37B	-85.70%	-57.50%	-37.61%	800.30%	0.22	6.47	100.00%	-478.30%	-478.33%
PASG	PASSAGE BIO INC	$25.92M	-135.00%	-60.40%	-116.13%	-188.10%	2.32	2.07	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.27B	-50.10%	-44.20%	-48.97%	-52.00%	0.13	9.16	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.86B	-70.80%	-64.00%	N/A	-1,546.50%	0.11	N/A	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$19.64B	-63.10%	-48.10%	-53.63%	-53.70%	0.44	7.15	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$776.05M	-23.20%	-14.00%	-19.18%	-29.00%	0.53	3.09	100.00%	-26.70%	-26.42%
NGNE	NEUROGENE INC	$322.23M	-33.00%	-30.40%	-33.19%	-41.80%	0.09	16.56	N/A	N/A	N/A
MBOT	MICROBOT MEDICAL INC	$161.18M	-24.40%	-23.10%	-16.82%	-26.20%	0.05	23.33	N/A	N/A	N/A
RCEL	AVITA MEDICAL INC	$113.64M	N/A	-78.40%	693.27%	-122.80%	-4.39	0.57	82.10%	-67.80%	-60.85%
MOH	MOLINA HEALTHCARE INC	$7.18B	11.00%	3.00%	9.53%	14.50%	2.83	1.69	9.00%	1.00%	1.72%
OSRH	OSR HOLDINGS INC	$18.22M	-33.90%	-15.30%	-18.42%	312.80%	0.57	0.16	20.40%	-931.20%	-977.14%
ACRV	ACRIVON THERAPEUTICS INC	$58.89M	-57.20%	-51.10%	-68.31%	-76.70%	0.15	7.69	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$473.50M	-101.20%	-73.40%	-31.04%	905.80%	0.12	10.01	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$535.47M	-30.20%	-28.50%	-21.20%	-42.40%	0.05	27.40	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$599.43M	-178.60%	-60.30%	-65.89%	-60.30%	1.84	4.84	100.00%	-4,342.40%	-4,342.44%
PCVX	VAXCYTE INC	$8.40B	-25.90%	-23.80%	-27.41%	-26.70%	0.12	7.91	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$368.94M	-14.20%	-13.90%	-9.94%	-46.90%	0.02	51.35	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$372.40M	-69.20%	-66.80%	-47.92%	-20,841.50%	0.07	15.12	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.49B	-32.80%	-30.20%	-27.03%	-35.40%	0.09	21.94	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.47B	-688.90%	-158.00%	-219.78%	-196.70%	7.67	3.18	N/A	N/A	N/A
PRCT	PROCEPT BIOROBOTICS CORP	$1.42B	-25.10%	-18.60%	-23.48%	-43.90%	0.39	6.85	63.70%	-31.00%	-33.71%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$180.38M	-65.80%	-57.90%	-53.24%	-80.20%	0.14	8.07	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$12.35B	-68.90%	-12.30%	-10.54%	-7.90%	6.21	3.83	98.30%	-40.40%	-30.63%
ACB	AURORA CANNABIS INC	$195.08M	-20.60%	-14.00%	-15.21%	-17.60%	0.39	3.06	34.50%	-30.20%	-25.65%
TMCI	TREACE MEDICAL CONCEPTS INC	$93.66M	-62.20%	-29.50%	-33.56%	-26.80%	1.18	4.31	79.80%	-27.70%	-25.24%
TYRA	TYRA BIOSCIENCES INC	$2.13B	-41.20%	-38.40%	-45.35%	-55.20%	0.09	14.67	N/A	N/A	N/A
STEX	STREAMEX CORP	$113.36M	-1,478.30%	-428.30%	-319.48%	980.30%	0.41	1.68	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$1.60B	-57.50%	-43.80%	-43.83%	-59.10%	0.28	7.02	100.00%	-314.90%	-314.00%
LITS	LITE STRATEGY INC	$40.73M	-68.90%	-67.50%	-48.50%	-91.70%	0.01	10.04	N/A	N/A	N/A
ARMP	ARMATA PHARMACEUTICALS INC	$372.92M	N/A	-207.90%	-231.41%	-100.70%	-1.35	1.19	N/A	N/A	N/A
RGNX	REGENXBIO INC	$440.26M	-103.10%	-37.80%	-44.45%	-27.00%	3.41	2.38	88.10%	-113.80%	-87.34%
PROK	PROKIDNEY CORP	$573.64M	N/A	-18.80%	-22.49%	-28.20%	-0.03	9.13	100.00%	-7,725.20%	-7,678.39%
OLMA	OLEMA PHARMACEUTICALS INC	$1.31B	-42.90%	-38.70%	-33.73%	-48.00%	0.12	9.95	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$2.92B	-59.70%	-49.10%	-42.87%	-56.70%	0.22	13.64	N/A	N/A	N/A
FBRX	FORTE BIOSCIENCES INC	$355.20M	-98.40%	-82.80%	-110.17%	697.20%	0.36	3.88	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$9.21M	-1,172.90%	-162.10%	-286.88%	-194.80%	-3.05	3.58	N/A	N/A	N/A
ACET	ADICET BIO INC	$67.08M	-83.00%	-68.00%	-68.36%	-87.70%	0.21	7.47	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.23B	-157.00%	-113.40%	-115.42%	-227.10%	0.58	5.61	100.00%	-3,777.40%	-3,704.89%
VRDN	VIRIDIAN THERAPEUTICS INC	$1.93B	-58.40%	-50.40%	-40.74%	-66.10%	0.25	12.65	100.00%	-483.60%	-476.58%
TARA	PROTARA THERAPEUTICS INC	$276.37M	-36.40%	-33.80%	-28.93%	-48.70%	0.07	14.58	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$15.03B	-296.80%	-251.00%	-159.19%	-794.50%	0.14	9.87	N/A	N/A	N/A
RNXT	RENOVORX INC	$44.17M	-119.80%	-91.20%	-182.10%	2,871.00%	0.49	4.02	70.90%	-994.50%	-994.48%
AARD	AARDVARK THERAPEUTICS INC	$93.81M	-44.60%	-41.50%	-54.01%	-60.50%	0.10	10.61	N/A	N/A	N/A
PHGE	BIOMX INC	$5.83M	-274.00%	-125.20%	5,947.65%	-207.00%	-5.44	0.87	N/A	N/A	N/A
RXST	RXSIGHT INC	$274.01M	-14.00%	-12.50%	-13.61%	-14.40%	0.13	10.95	76.60%	-29.00%	-28.90%
CLDX	CELLDEX THERAPEUTICS INC	$2.07B	-41.70%	-38.90%	-48.64%	-45.00%	0.11	10.49	100.00%	-16,748.00%	-16,748.03%
KURA	KURA ONCOLOGY INC	$760.52M	-102.60%	-39.60%	-44.55%	-53.20%	3.24	6.06	99.90%	-412.90%	-410.27%
EYPT	EYEPOINT INC	$1.12B	-88.30%	-72.50%	-70.85%	-104.10%	0.19	8.88	93.40%	-739.40%	-738.42%
MDWD	MEDIWOUND LTD	$215.76M	-65.80%	-30.20%	-35.10%	-60.20%	0.98	2.33	19.20%	-140.80%	-125.30%
RZLT	REZOLUTE INC	$298.58M	-64.80%	-59.40%	-65.24%	-83.90%	0.08	14.18	N/A	N/A	N/A
RADX	RADIOPHARM THERANOSTICS LTD	$31.22M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
KRRO	KORRO BIO INC	$201.92M	-115.90%	-71.30%	-114.82%	-73.40%	1.21	6.90	100.00%	-1,834.50%	-1,824.52%
LENZ	LENZ THERAPEUTICS INC	$303.20M	-37.50%	-35.10%	-28.67%	-42.40%	0.08	14.23	97.80%	-430.30%	-427.62%
BEAT	HEARTBEAM INC	$48.48M	-571.10%	-353.10%	-807.34%	-10,031.00%	1.25	1.45	N/A	N/A	N/A
CMPS	COMPASS PATHWAYS PLC	$746.47M	-335.90%	-106.80%	763.28%	1,044.50%	-4.98	0.77	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$1.25B	-68.00%	-50.90%	-58.70%	-126.40%	0.39	9.27	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$171.97M	-204.10%	-121.40%	-164.57%	-330.20%	0.94	4.39	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$64.65M	-159.40%	-133.50%	-165.39%	28,750.00%	0.25	5.80	N/A	N/A	N/A
OSTX	OS THERAPIES INC	$53.77M	N/A	-378.90%	583.84%	565.00%	-1.95	0.03	N/A	N/A	N/A
CADL	CANDEL THERAPEUTICS INC	$366.23M	-51.40%	-36.30%	-31.04%	-354.50%	1.41	13.49	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$824.17M	-100.30%	-51.10%	-58.50%	-47.60%	1.87	7.28	75.80%	-203.30%	-200.26%
CVKD	CADRENAL THERAPEUTICS INC	$11.78M	-333.30%	-237.00%	-483.34%	1,083.00%	0.58	2.72	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$497.60M	-137.70%	-101.40%	-204.42%	-226.30%	0.87	2.19	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$274.98M	53.20%	35.80%	39.49%	67.10%	0.38	6.93	73.70%	1,223.10%	1,289.05%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$228.24M	-29.10%	-22.00%	-28.02%	-162.50%	0.27	6.64	100.00%	-80.20%	-80.19%
HELP	CYBIN INC	$255.46M	-65.60%	-55.90%	-48.03%	-428.20%	0.06	13.78	N/A	N/A	N/A
PFSA	PROFUSA INC	$663.82k	N/A	-695.90%	146.77%	1,288.50%	-1.13	0.18	100.00%	-35,359.40%	-28,311.39%
VKTX	VIKING THERAPEUTICS INC	$4.02B	-48.00%	-45.70%	-56.28%	-54.10%	0.12	9.33	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.